Xavier Causse

2.7k total citations
52 papers, 898 citations indexed

About

Xavier Causse is a scholar working on Epidemiology, Hepatology and Hematology. According to data from OpenAlex, Xavier Causse has authored 52 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 32 papers in Hepatology and 6 papers in Hematology. Recurrent topics in Xavier Causse's work include Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (22 papers) and Liver Disease Diagnosis and Treatment (21 papers). Xavier Causse is often cited by papers focused on Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (22 papers) and Liver Disease Diagnosis and Treatment (21 papers). Xavier Causse collaborates with scholars based in France, Belgium and Poland. Xavier Causse's co-authors include P. Chossegros, C. Trépo, Noboru MANABE, M. Chevallier, J.A. Grimaud, Christian Trépo, M. Berruyer, M Dechavanne, Sylviane Guérret and Michèle Chevallier and has published in prestigious journals such as Hepatology, Cancer and Journal of Hepatology.

In The Last Decade

Xavier Causse

52 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Causse France 14 614 565 120 98 73 52 898
William M. Lee United States 14 811 1.3× 658 1.2× 70 0.6× 153 1.6× 43 0.6× 17 1.1k
Sebastián Marciano Argentina 17 627 1.0× 564 1.0× 69 0.6× 152 1.6× 33 0.5× 82 890
Paul J. Gaglio United States 18 761 1.2× 622 1.1× 87 0.7× 227 2.3× 51 0.7× 57 973
Pilar López Serrano Spain 14 606 1.0× 813 1.4× 77 0.6× 166 1.7× 66 0.9× 41 1.1k
Manuel Mendizábal Argentina 17 502 0.8× 610 1.1× 71 0.6× 245 2.5× 97 1.3× 65 1.1k
Marc Vallée United States 9 314 0.5× 433 0.8× 146 1.2× 75 0.8× 44 0.6× 18 808
Atilla Ökten Türkiye 18 525 0.9× 530 0.9× 103 0.9× 325 3.3× 23 0.3× 48 922
Annarosa Cussigh Italy 18 624 1.0× 771 1.4× 91 0.8× 70 0.7× 304 4.2× 31 1.2k
M. De Palma Italy 12 513 0.8× 600 1.1× 66 0.6× 49 0.5× 59 0.8× 29 914
F. Noventa Italy 16 873 1.4× 900 1.6× 70 0.6× 133 1.4× 61 0.8× 28 1.4k

Countries citing papers authored by Xavier Causse

Since Specialization
Citations

This map shows the geographic impact of Xavier Causse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Causse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Causse more than expected).

Fields of papers citing papers by Xavier Causse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Causse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Causse. The network helps show where Xavier Causse may publish in the future.

Co-authorship network of co-authors of Xavier Causse

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Causse. A scholar is included among the top collaborators of Xavier Causse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Causse. Xavier Causse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Causse, Xavier, Pascal Potier, Antoine Valéry, et al.. (2024). Predictive Factors for HBsAg Loss in Chronic HBeAg‐Negative Hepatitis B Virus Infection: Insights From a 5‐Year French Cohort. Journal of Viral Hepatitis. 32(1). e14041–e14041. 1 indexed citations
2.
Bronowicki, J.-P., Patrick Miailhes, Denis Ouzan, et al.. (2022). An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study). Health Science Reports. 6(1). e619–e619. 1 indexed citations
3.
Hamdi‐Rozé, Houda, Séverine Cunat, V. Loustaud‐Ratti, et al.. (2021). A simple clinical score to promote and enhance ferroportin disease screening. Journal of Hepatology. 76(3). 568–576. 5 indexed citations
4.
Leroy, Vincent, Stéphane Chevaliez, Dominique Roulot, et al.. (2021). Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus. Clinics and Research in Hepatology and Gastroenterology. 46(8). 101773–101773. 3 indexed citations
5.
Marlet, Julien, Alain Moreau, Sandrine Lefeuvre, et al.. (2020). Revisiting HBV resistance to entecavir with a phenotypic approach. Antiviral Research. 181. 104869–104869. 3 indexed citations
6.
Amiot, Xavier, Isabelle Ollivier‐Hourmand, Christophe Renou, et al.. (2019). Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients. European Journal of Gastroenterology & Hepatology. 31(10). 1270–1274. 1 indexed citations
7.
Barbier, Louise, Petru Bucur, Jean–Marc Perarnau, et al.. (2018). Recipient Selection for Optimal Utilization of Discarded Grafts in Liver Transplantation. Transplantation. 102(5). 775–782. 15 indexed citations
8.
Marcellin, Patrick, Fabien Zoulim, Christophe Hézode, et al.. (2016). Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France. Digestive Diseases and Sciences. 61(10). 3072–3083. 48 indexed citations
9.
Lesgourgues, Bruno, Bernard Nalet, Xavier Causse, et al.. (2014). Renal dysfunction associated with telaprevir-containing triple therapy for chronic hepatitis C. European Journal of Gastroenterology & Hepatology. 26(9). 996–1002. 3 indexed citations
10.
Leblebicioğlu, Hakan, Victoria Aramă, Xavier Causse, et al.. (2013). Predictors associated with treatment initiation and switch in a real‐world chronic hepatitis B population from five European countries. Journal of Viral Hepatitis. 21(9). 662–670. 8 indexed citations
11.
Marcellin, Patrick, Fabien Zoulim, Xavier Causse, et al.. (2012). 531 TENOFOVIR DF TREATMENT IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH BASELINE DECREASED GLOMERULAR FILTRATION RATE. Journal of Hepatology. 56. S210–S210. 5 indexed citations
12.
Causse, Xavier, et al.. (2009). Anaes practice guidelines for vaccination against hepatitis B virus: Impact on general practitioners. Gastroentérologie Clinique et Biologique. 33(12). 1166–1170. 5 indexed citations
13.
Lédinghen, Victor de, Vlad Ratziu, Xavier Causse, et al.. (2006). Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. Journal of Hepatology. 45(4). 592–599. 56 indexed citations
14.
Causse, Xavier, Si Nafa Si Ahmed, Jacques Gros, et al.. (2005). Treatment of chronic hepatitis C in patients unresponsive to interferon. Gastroentérologie Clinique et Biologique. 29(2). 117–121. 1 indexed citations
15.
Lunel, F., Pascal Veillon, I. Fouchard‐Hubert, et al.. (2003). Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen. Journal of Hepatology. 39(5). 826–833. 24 indexed citations
16.
Lagasse, J.-P., et al.. (1998). Cytomegalovirus Gastritis Simulating Cancer of the Linitis Plastica Type on Endoscopic Ultrasonography. Endoscopy. 30(9). S 101–S 102. 3 indexed citations
17.
Maynard-Muet, M., S. Chousterman, R Barnoud, et al.. (1998). Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon. Hepatology. 27(3). 862–867. 25 indexed citations
18.
Causse, Xavier, et al.. (1994). A Case of Association between Hepatocellular Carcinoma and Porphyria Variegata. Scandinavian Journal of Gastroenterology. 29(7). 671–672. 4 indexed citations
19.
Zarski, Jean‐Pierre, Xavier Causse, Marielle Cohard, Jean Cougnard, & Christian Trépo. (1994). A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. Journal of Hepatology. 20(6). 735–741. 11 indexed citations
20.
Berruyer, M., et al.. (1992). Acquired Protein S Deficiency. PubMed. 5(5). 484???489–484???489. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026